Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for livestock, poultry, and pets. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China.
Frequently asked questions
What sector does Pulike Biological Engineering (603566) operate in?
Pulike Biological Engineering belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Pulike Biological Engineering (603566) current stock price?
As of the latest data, Pulike Biological Engineering stock price is CN¥10.19, with a previous close of CN¥10.19.
What is Pulike Biological Engineering (603566) current market capitalization?
Pulike Biological Engineering market cap is approximately 3.53 billion.
What is Pulike Biological Engineering (603566) Earnings Per Share (EPS)?
The trailing EPS is CN¥0.43, and the forward EPS is CN¥0.82.
What is Pulike Biological Engineering (603566) Price-to-Earnings (P/E) ratio?
Pulike Biological Engineering current P/E ratio is 23.7, with a forward P/E of 12.43.
Does Pulike Biological Engineering (603566) pay dividends?
No. Pulike Biological Engineering does not pay a dividend.
What is Pulike Biological Engineering (603566) beta (volatility) score?
Pulike Biological Engineering has a beta of 0.296, indicating lower volatility than the overall market.